Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that its Board of Directors will meet on Friday, February 13, 2026, to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and nine months ended December 31, 2025 (Q3 FY26 and 9M FY26). The filing is a routine regulatory disclosure under SEBI's Listing Regulations. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the results are declared. No financial numbers or outcomes are disclosed at this stage — this is only an advance notice of the upcoming board meeting.
No direct impact on shareholders or stock price from this notice alone. Investors should await the actual Q3 FY26 results on February 13, 2026, for any meaningful signal on revenue, profitability, or outlook.